Out of the patients diagnosed with moderately-poor differentiated HCC, 65 had a mean AFP level of 2134.73±6158.24 ng/L, mean CA19-9 level of 113.29±356.71 U/mL and mean CEA level of 4.51±7.83 ng/L and two patients only were positive for all the three biomarkers, as shown in (Table 4). The gene discussed is AFP; the disease is hepatocellular carcinoma.